ArticleFrontiers in pharmacology2022

Angiotensin II Receptor Blocker Associated With Less Outcome Risk in Patients With Acute Kidney Disease.

Vin-Cent Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.